Clin2
NCT07527221Possibly a fitRecruiting

Safety study of ZE74-0282 in healthy adults

Healthy Volunteers

Part of Blood & lymphatic, Cancer clinical trials.

This is an early-stage safety study testing a new experimental drug called ZE74-0282 in healthy volunteers. Researchers want to learn how safe the drug is and how well people tolerate it before testing it in patients with a disease.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
64 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • Be between 18 and 55 years old and in generally good health
  • Have a normal weight range (BMI 18–32, under 100 kg)
  • Have normal heart function, blood pressure, and vital signs
  • Not be pregnant, breastfeeding, or planning pregnancy during the study and for 30–90 days after
  • Not take most medications, supplements, or vaccines in the weeks before and during the study
  • Not have a history of serious illness, heart disease, or liver/kidney problems

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07658638Recruiting· Phase 1
Safety study of TESP-0401 in healthy volunteers

This study tests a new oral medication, TESP-0401, in healthy volunteers to check its safety, how the body processes it, and any side effects. It is a first-in-human trial, so participants help determine if the drug is safe enough for future studies.

Charlestown, Suite 301, 99 Pacific Highway,NSW
NCT06682975Recruiting· Phase 1
Safety study of ZP9830 in healthy people

This study tests a new medicine called ZP9830 to see if it is safe for people and how it works in the body. Healthy volunteers aged 18 to 45 can join.

Leiden, CL
NCT07658482Not yet recruiting· Phase 1
Study of ZL-1503 in healthy volunteers

This study is testing a new medicine called ZL-1503 in healthy volunteers to see how the body processes it and if it's safe. You may be able to join if you are in good health and meet certain age, weight, and lifestyle requirements.

Auckland, Auckland
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07271693Recruiting· Phase 1
Safety study of a new medicine in healthy volunteers

This trial tests a new medicine called RO7806881 in healthy volunteers to see if it is safe, what dose is best, and how the body handles it. It is an early study that helps researchers decide if the drug should be tested in people with a disease.

Christchurch
NCT07735728Not yet recruiting· Phase 1
Testing ZE66-0205 in healthy volunteers

This study is testing a new medicine called ZE66-0205 for the first time in people. It is looking at healthy volunteers to see how the drug is processed by the body and if it is safe.

Randwick, New South Wales

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.